Pact With NCI Expands Veterans' Access to Trials
BETHESDA, Md--In a move designed to increase the pool of patients available for clinical trials, the National Cancer Institute has forged an agreement with the Department of Veterans Affairs that will increase the ability of veterans to enroll in phase I, II, and III studies.
BETHESDA, Md--In a move designed to increase the pool of patients availablefor clinical trials, the National Cancer Institute has forged an agreementwith the Department of Veterans Affairs that will increase the abilityof veterans to enroll in phase I, II, and III studies.
Under the agreement, the VA will provide medical coverage for eligibleveterans who participate in NCI-supported studies at non-VA facilities.The pact also envisions that more NCI studies will be conducted in VA hospitalsand clinics.
"Developing an expanded pool of VA cancer researchers will strengthenour clinical research program across the board," said Robert Wittes,MD, director of NCI's Division of Cancer Treatment, Diagnosis, and Centers.
Maintenance Tucatinib Combo Yields PFS Extension in Advanced HER2+ Breast Cancer
December 11th 2025“HER2CLIMB-05 has demonstrated that the addition of tucatinib to HP represents an enhanced frontline maintenance therapy option for patients with HER2-positive metastatic breast cancer,” said Erika Hamilton, MD.
